Abstract:PurposeThe aim of the present study is to assess the impact of adding oral metformin to insulin therapy in pregnant women with insulin-resistant diabetes mellitus.MethodsThe current non-inferiority randomized controlled trial was conducted at Ain Shams University Maternity Hospital. The study included pregnant women with gestational or pre-existing diabetes mellitus at gestations between 20 and 34 weeks, who showed insulin resistance (defined as poor glycemic control at a daily dose of ≥1.12 units/kg). Recruited women were randomized into one of two groups: group I, including women who received oral metformin without increasing the insulin dose; and group II, including women who had their insulin dose increased. The primary outcome was maternal glycemic control. Secondary outcomes included maternal bouts of hypoglycemia, need for another hospital admission for uncontrolled diabetes during pregnancy, gestational age at delivery, mode of delivery, birth weight, birth trauma, congenital anomalies, 1- and 5-min Apgar score, neonatal hypoglycemia, need for neonatal intensive care unit (NICU) admission and adverse neonatal outcomes.ResultsA total number of 154 women with diabetes mellitus with pregnancy were approached; of them 90 women were eligible and were randomly allocated and included in the final analysis. The recruited 90 women were randomized into one of two groups: group I (metformin group) (n = 46), including women who received oral metformin in addition to the same initial insulin dose; and group II (control group) (n = 44), including women who had their insulin dose increased according to the standard protocol. The mean age of included women was 29.84 ± 5.37 years (range 20–42 years). The mean gestational age at recruitment was 28.7 ± 3.71 weeks (range 21–34 weeks). Among the 46 women of group I, 17 (36.9 %) women reached proper glycemic control at a daily metformin dose of 1,500 mg, 18 (39.2 %) at a daily dose of 2,000 mg, while 11 (23.9 %) received metformin at a daily dose of 2,000 mg without reaching proper glycemic control and needed raising the dose of insulin dose.ConclusionAdding metformin to insulin therapy in women with insulin-resistant diabetes mellitus with pregnancy seems to be effective in proper glycemic control in a considerable proportion of women, along with benefits of reduced hospital stay, reduced frequency of maternal hypoglycemia as well as reduced frequency of neonatal hypoglycemia, NICU admission and neonatal respiratory distress syndrome.

Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy

Glycemic Control and Neonatal Outcomes in Women with Gestational Diabetes Mellitus Treated Using Glyburide, Metformin, or Insulin: A Pairwise and Network Meta-Analysis

Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia

Early Metformin in Gestational Diabetes

Metformin versus Insulin in Treatment of Gestational Diabetes

Perinatal Outcomes Associated With Metformin Use During Pregnancy in Women With Pregestational Type 2 Diabetes Mellitus

Treatment of Diabetes in Pregnancy With Metformin

Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: A population‐based cohort study

Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations: Emulating a Target Trial Using Real-World Data

The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial

Is metformin safe in pregnancy: a focus on offspring outcomes

Pregnancy outcomes in pregnant women with diabetes treated with insulin alone and insulin with metformin

A meta-analysis of metformin and insulin on maternal outcome and neonatal outcome in patients with gestational diabetes mellitus

Introduction of metformin for gestational diabetes mellitus in clinical practice: has it had an impact?

Metformin for Diabetes in Pregnancy: Are We Closer to Defining its Role?

Effect of metformin on pregnancy outcome and neonates in gestational diabetes mellitus

Use of metformin and insulin among pregnant women with gestation diabetes in the United Kingdom: A population-based cohort study

Metformin in the management of diabetes during pregnancy and lactation

Clinical Experience of Metformin in Treating Patients with Hyperglycemia in Pregnancy

Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question

Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis